Axogen (AXGN) Cash from Investing Activities (2010 - 2026)
Axogen (AXGN) posted Cash from Investing Activities of $500000.0 for Q2 2026, up 103.13% on a QoQ basis from -$16.0 million in Q1 2026, and up 107.2% year-over-year from $241315.8 in Q2 2025.
Analysis
Axogen (AXGN) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Axogen has reported Cash from Investing Activities for 17 years, with the latest figure at $500000.0 in Q2 2026.
- On a quarterly basis, Cash from Investing Activities rose 107.2% year-over-year to $500000.0 in Q2 2026; TTM through Jun 2026 was -$15.2 million, a 32.85% decrease from a year earlier, with the FY2025 full-year figure at -$5.3 million, up 48.36% from the prior year.
- Cash from Investing Activities was $500000.0 for Q2 2026 at Axogen, up from -$16.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $14.3 million in Q2 2023, with the low at -$16.0 million in Q1 2026.
- Average Cash from Investing Activities over 5 years is -$834722.2, with a median of -$799500.0 recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities surged 597.17% in 2025, then plunged 1292.23% in 2026.
- Over 5 years, Cash from Investing Activities stood at -$1.2 million in 2022, then surged by 77.09% to -$277000.0 in 2023, then plunged by 193.5% to -$813000.0 in 2024, then soared by 597.17% to $4.0 million in 2025, then plunged by 87.63% to $500000.0 in 2026.
- The last three Cash from Investing Activities figures came in at $500000.0 (Q2 2026), -$16.0 million (Q1 2026), and $4.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Axogen | 2.59 Bn | 2.48 Bn | 50.67 Mn | 500,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 500,000.00 |
| Mar 31, 2026 | -15.96 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | -3.75 Mn |
| Jun 30, 2025 | -6.95 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | -813,000.00 |
| Sep 30, 2024 | -5.00 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Dec 31, 2023 | -277,000.00 |
| Sep 30, 2023 | 5.99 Mn |
| Jun 30, 2023 | 14.32 Mn |
| Mar 31, 2023 | -786,000.00 |
| Dec 31, 2022 | -1.21 Mn |
| Sep 30, 2022 | 2.97 Mn |
| Jun 30, 2022 | 2.28 Mn |
| Mar 31, 2022 | -7.24 Mn |
| Dec 31, 2021 | -13.59 Mn |
| Sep 30, 2021 | -6.78 Mn |